Jesper Bøje Andersen

Jesper Bøje Andersen

Professor

ORCID: 0000-0003-1760-5244

Publication year:
All
1 - 10 out of 139Page size: 10
  1. 2004

  2. Interaction between the 2'-5' oligoadenylate synthetase-like protein p59 OASL and the transcriptional repressor methyl CpG-binding protein 1

    Andersen, Jesper Bøje, Strandbygård, D. J., Hartmann, R. & Justesen, J., Feb 2004, In: European Journal of Biochemistry. 271, 3, p. 628-36 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. 2006

  4. Stage-associated overexpression of the ubiquitin-like protein, ISG15, in bladder cancer

    Andersen, Jesper Bøje, Aaboe, M., Borden, E. C., Goloubeva, O. G., Hassel, B. A. & Orntoft, T. F., 22 May 2006, In: B J C. 94, 10, p. 1465-71 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. The interferon regulated ubiquitin-like protein, ISG15, in tumorigenesis: friend or foe?

    Andersen, Jesper Bøje & Hassel, B. A., Dec 2006, In: Cytokine & Growth Factor Reviews. 17, 6, p. 411-21 11 p.

    Research output: Contribution to journal › Review › Research › peer-review

  6. 2007

  7. Role of 2-5A-dependent RNase-L in senescence and longevity

    Andersen, Jesper Bøje, Li, X. L., Judge, C. S., Zhou, A., Jha, B. K., Shelby, S., Zhou, L., Silverman, R. H. & Hassel, B. A., 10 May 2007, In: Oncogene. 26, 21, p. 3081-8 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Post-transcriptional regulation of RNase-L expression is mediated by the 3'-untranslated region of its mRNA

    Li, X., Andersen, Jesper Bøje, Ezelle, H. J., Wilson, G. M. & Hassel, B. A., 16 Mar 2007, In: The Journal of Biological Chemistry. 282, 11, p. 7950-60 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. 2008

  10. UBE1L causes lung cancer growth suppression by targeting cyclin D1

    Feng, Q., Sekula, D., Guo, Y., Liu, X., Black, C. C., Galimberti, F., Shah, S. J., Sempere, L. F., Memoli, V., Andersen, Jesper Bøje, Hassel, B. A., Dragnev, K. & Dmitrovsky, E., Dec 2008, In: Molecular Cancer Therapeutics. 7, 12, p. 3780-8 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. 2009

  12. Ribosomal protein mRNAs are primary targets of regulation in RNase-L-induced senescence

    Andersen, Jesper Bøje, Mazan-Mamczarz, K., Zhan, M., Gorospe, M. & Hassel, B. A., 2009, In: RNA Biology. 6, 3, p. 305-15 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  13. Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties

    Coulouarn, C., Factor, V. M., Andersen, Jesper Bøje, Durkin, M. E. & Thorgeirsson, S. S., 8 Oct 2009, In: Oncogene. 28, 40, p. 3526-36 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  14. 2010

  15. An integrated genomic and epigenomic approach predicts therapeutic response to zebularine in human liver cancer

    Andersen, Jesper Bøje, Factor, V. M., Marquardt, J. U., Raggi, C., Lee, Y., Seo, D., Conner, E. A. & Thorgeirsson, S. S., 20 Oct 2010, In: Science Translational Medicine. 2, 54, p. 54ra77

    Research output: Contribution to journal › Journal article › Research › peer-review

  16. Progenitor-derived hepatocellular carcinoma model in the rat

    Andersen, Jesper Bøje, Loi, R., Perra, A., Factor, V. M., Ledda-Columbano, G. M., Columbano, A. & Thorgeirsson, S. S., Apr 2010, In: Hepatology. 51, 4, p. 1401-9 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 7 8 ...14 Next

ID: 93714085